Company Filing History:
Years Active: 2012
Title: The Innovations of Stefan Braith
Introduction
Stefan Braith is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of pharmacology through his innovative processes. His work focuses on the stereoselective preparation of bicyclic heterocycles, which have valuable applications in medicine.
Latest Patents
Stefan Braith holds a patent for a process that enables the stereoselective preparation of compounds of general formula (I) and their physiologically acceptable salts. This invention is particularly relevant for its pharmacological properties, especially its inhibitory effect on signal transduction mediated by tyrosine kinases. The compounds developed through this process are intended for the treatment of various diseases, including tumoral diseases and benign prostatic hyperplasia (BPH), as well as diseases affecting the lungs and airways. He has 1 patent to his name.
Career Highlights
Stefan Braith is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has allowed him to contribute to important advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, Stefan has collaborated with esteemed colleagues such as Markus Ostermeier and Juergen Daeubler. These partnerships have fostered a collaborative environment that enhances innovation and research.
Conclusion
Stefan Braith's contributions to the field of pharmacology through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the treatment of significant health issues, showcasing the importance of innovation in the pharmaceutical industry.